Page last updated: 2024-11-04

rolipram and Lewy Body Disease

rolipram has been researched along with Lewy Body Disease in 1 studies

Lewy Body Disease: A neurodegenerative disease characterized by dementia, mild parkinsonism, and fluctuations in attention and alertness. The neuropsychiatric manifestations tend to precede the onset of bradykinesia, MUSCLE RIGIDITY, and other extrapyramidal signs. DELUSIONS and visual HALLUCINATIONS are relatively frequent in this condition. Histologic examination reveals LEWY BODIES in the CEREBRAL CORTEX and BRAIN STEM. SENILE PLAQUES and other pathologic features characteristic of ALZHEIMER DISEASE may also be present. (From Neurology 1997;48:376-380; Neurology 1996;47:1113-1124)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Winner, B1
Regensburger, M1
Schreglmann, S1
Boyer, L1
Prots, I1
Rockenstein, E1
Mante, M1
Zhao, C1
Winkler, J1
Masliah, E1
Gage, FH1

Other Studies

1 other study available for rolipram and Lewy Body Disease

ArticleYear
Role of α-synuclein in adult neurogenesis and neuronal maturation in the dentate gyrus.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2012, Nov-21, Volume: 32, Issue:47

    Topics: Aged, 80 and over; alpha-Synuclein; Animals; beta-Synuclein; Cell Count; Dendrites; Dendritic Spines

2012